Evidence map›Paper›PMID 34944740›Full record

ArticleBiomedicines2021

Relevance of Dynamic

Shamimeh Ahrari, Timothée Zaragori, Laura Rozenblum, Julien Oster, Laëtitia Imbert, Aurélie Kas, Antoine Verger

Abstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shamimeh AhrariUniversité de Lorraine, IADI, INSERM, UMR 1254, F-54000 Nancy, France.ORCID 0000-0003-0422-5808
Timothée ZaragoriUniversité de Lorraine, IADI, INSERM, UMR 1254, F-54000 Nancy, France.ORCID 0000-0002-2050-3591
Laura RozenblumSorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, Service de Médecine Nucléaire and LIB, INSERM U1146, F-75013 Paris, France.
Julien OsterUniversité de Lorraine, IADI, INSERM, UMR 1254, F-54000 Nancy, France.
Laëtitia ImbertUniversité de Lorraine, IADI, INSERM, UMR 1254, F-54000 Nancy, France.
Aurélie KasSorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, Service de Médecine Nucléaire and LIB, INSERM U1146, F-75013 Paris, France.ORCID 0000-0001-9463-3658
Antoine VergerUniversité de Lorraine, IADI, INSERM, UMR 1254, F-54000 Nancy, France.ORCID 0000-0003-2194-0328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluates the relevance of

Indexed as

DOPA PETdynamicgliomaradiomicsrecurrence

Identifiers

PMID34944740
PMCPMC8698938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.